KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Payables (2016 - 2025)

LifeMD (LFMD) has disclosed Payables for 14 consecutive years, with $14.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Payables rose 27.78% year-over-year to $14.9 million, compared with a TTM value of $14.9 million through Dec 2025, up 27.78%, and an annual FY2025 reading of $14.9 million, up 27.78% over the prior year.
  • Payables was $14.9 million for Q4 2025 at LifeMD, down from $20.3 million in the prior quarter.
  • Across five years, Payables topped out at $325.4 million in Q3 2023 and bottomed at $9.3 million in Q3 2021.
  • Average Payables over 5 years is $29.3 million, with a median of $12.6 million recorded in 2022.
  • The sharpest move saw Payables surged 2711.57% in 2023, then tumbled 94.89% in 2024.
  • Year by year, Payables stood at $10.0 million in 2021, then increased by 8.9% to $10.9 million in 2022, then rose by 12.0% to $12.2 million in 2023, then fell by 4.17% to $11.7 million in 2024, then grew by 27.78% to $14.9 million in 2025.
  • Business Quant data shows Payables for LFMD at $14.9 million in Q4 2025, $20.3 million in Q3 2025, and $25.1 million in Q2 2025.